In honor of Cholangiocarcinoma Awareness Month in February, we’re raising awareness about biliary tract cancer (BTC), the role HER2 expression plays in this type of cancer, and Jazz’s commitment to supporting patients with rare diseases such as BTC. This month is particularly important for people diagnosed with BTC, as well as their families and caregivers, and we’re highlighting our approach to seeking innovative solutions for them so they can live their lives more fully.
Our presence at SABCS 2023 marks a significant step forward for Jazz as our oncology pipeline continues to evolve to address new tumor types such as breast cancer. We’re excited to gather with leaders in the breast cancer community and share our research, including findings for our HER2-targeted bispecific antibody in HER2+ breast cancer, which reflects our continuous dedication to reshaping cancer care and addressing unmet needs.
November is National Epilepsy Awareness Month – a milestone that allows us to pause and reflect on both the progress the community has made for people living with this condition and their continued unmet needs. This time of reflection is especially important for people diagnosed with rare forms of epilepsy, as well as their families and caregivers, who are continuing to search for improved therapeutic outcomes.
Recently, Mat Davis, PhD, vice president and head of data science, presented at the 2023 STAT Summit where he shared a key moment in his career when he learned the necessity of breaking down silos to fully embrace quantitative experts across the three avenues of drug development.
Jazz’s oncology efforts are focused on delivering innovation to improve patient care, quality of life, and advancing scientific understanding of cancers with high unmet needs like acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL), which often affect children. To learn more about progress in the fight against these childhood blood cancers, Jazz’s Abizer Gaslightwala spoke with pediatric hematologist/oncologist Dr. Rachel Rau.
As World Heart Day approaches, we are reminded of people who live with complex sleep disorders and how we can adequately address their unique needs. Learn more about the importance of thinking holistically about narcolepsy and idiopathic hypersomnia patients’ health from Jazz’s Dr. Kelvin Tan and Dr. Logan Schneider of the Stanford University School of Medicine.
This page is for U.S. residents only. By clicking on this page, you confirm you are a U.S. resident.
Thank you for visiting JazzPharma.com. The site you are about to visit is maintained by a third party who is solely responsible for its content; Jazz Pharmaceuticals is not responsible for the content or privacy practices of any third-party websites. Click Cancel to return or OK to continue.